Cargando…

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models

BACKGROUND: The World Health Organization (WHO) recommends that the cost effectiveness of introducing human papillomavirus (HPV) vaccination is considered before such a strategy is implemented. However, developing countries often lack the technical capacity to perform and interpret results of econom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jit, Mark, Demarteau, Nadia, Elbasha, Elamin, Ginsberg, Gary, Kim, Jane, Praditsitthikorn, Naiyana, Sinanovic, Edina, Hutubessy, Raymond
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123559/ https://www.ncbi.nlm.nih.gov/pubmed/21569406 http://dx.doi.org/10.1186/1741-7015-9-54

Ejemplares similares

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

Q&A - Economic analyses for vaccine introduction decisions in low- and middle- income countries
por: Hutubessy, Raymond
Publicado: (2013)

Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis
por: Drolet, Mélanie, et al.
Publicado: (2021)

Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
por: Ochalek, Jessica, et al.
Publicado: (2020)

Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries
por: Deogaonkar, Rohan, et al.
Publicado: (2012)

What works for human papillomavirus vaccine introduction in low and middle-income countries?
por: Howard, Natasha, et al.
Publicado: (2017)

Costs of Introducing and Delivering HPV Vaccines in Low and Lower Middle Income Countries: Inputs for GAVI Policy on Introduction Grant Support to Countries
por: Levin, Ann, et al.
Publicado: (2014)

Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts
por: Jit, Mark, et al.
Publicado: (2013)

Stakeholders’ perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study
por: van der Putten, Ingeborg M, et al.
Publicado: (2015)

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study
por: Clark, Rebecca A, et al.
Publicado: (2023)

Screening for Human Papillomavirus in a Low- and Middle-Income Country
por: Atkinson, Aaron E., et al.
Publicado: (2019)

Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework
por: Carvalho, Natalie, et al.
Publicado: (2017)

The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries
por: Howard, N., et al.
Publicado: (2016)

National tuberculosis spending efficiency and its associated factors in 121 low-income and middle-income countries, 2010–19: a data envelopment and stochastic frontier analysis
por: Abou Jaoude, Gerard Joseph, et al.
Publicado: (2022)

Introduction: Discovering Issues and Challenges in Low- and Middle-Income Countries
por: Ibrahim, Mohamed Izham Mohamed, et al.
Publicado: (2018)

Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis
por: Bénard, Élodie, et al.
Publicado: (2022)

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study
por: Portnoy, Allison, et al.
Publicado: (2023)

Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis
por: Portnoy, Allison, et al.
Publicado: (2019)

Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis
por: Dorji, Thinley, et al.
Publicado: (2021)

Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective
por: Ebrahimi, Narges, et al.
Publicado: (2023)

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
por: Brisson, Marc, et al.
Publicado: (2020)

Management of neonatal jaundice in low-income and middle-income countries
por: Erdeve, Omer
Publicado: (2020)

Tackling antimicrobial resistance in low-income and middle-income countries
por: Pokharel, Sunil, et al.
Publicado: (2019)

Rotavirus vaccine protection in low-income and middle-income countries
por: Ramakrishnan, Girija, et al.
Publicado: (2019)

Improving childhood vaccination in low-income and middle-income countries
por: eBioMedicine
Publicado: (2023)

Exceptional Financial Support for Introduction of Inactivated Polio Vaccine in Middle-Income Countries
por: Blankenhorn, Anne-Line, et al.
Publicado: (2017)

Ethical guidance for health research in prisons in low- and middle-income countries: a scoping review
por: Ako, T., et al.
Publicado: (2020)

Societal challenges facing neurosurgeons in low- and middle-income countries: Iraq as an example
por: Ismail, Mustafa, et al.
Publicado: (2023)

The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries
por: Portnoy, Allison, et al.
Publicado: (2023)

Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007–2016
por: Gallagher, Katherine E., et al.
Publicado: (2017)

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries
por: Gallagher, Katherine E., et al.
Publicado: (2017)

Tobacco Control Progress in Low and Middle Income Countries in Comparison to High Income Countries
por: Anderson, Carrie L., et al.
Publicado: (2016)

Perceptions and impact of plain packaging of tobacco products in low and middle income countries, middle to upper income countries and low-income settings in high-income countries: a systematic review of the literature
por: Hughes, Nicole, et al.
Publicado: (2016)

Dementia in low- and middle-income countries
por: Graham, Nori
Publicado: (2006)

Specialization in acute care surgery in low-income and middle-income countries
por: Yi, Sojung, et al.
Publicado: (2017)

Achieving affordable critical care in low-income and middle-income countries
por: Turner, Hugo C, et al.
Publicado: (2019)

Emergency care research ethics in low-income and middle-income countries
por: Millum, Joseph, et al.
Publicado: (2019)

Maximizing the potential of trauma registries in low-income and middle-income countries
por: Rosenkrantz, Leah, et al.
Publicado: (2020)

Controlling infectious disease outbreaks in low-income and middle-income countries
por: Caeiro, Juan Pablo, et al.
Publicado: (2018)

Strengthening medical specialisation policy in low-income and middle-income countries
por: Sriram, Veena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tutanii0pjt8m4chaa5jl5tkqj